EN1-4. Long-term outcomes with sotorasib, including genomic profiles, in pretreated KRAS p.G12C mutated NSCLC : 2-year analysis of CodeBreaK100 von Toshiaki Takahashi, Grace K.Dy, Ramaswamy Govindan, Vamsidhar Velcheti, Gerald S.Falchook, Antoine Italiano, Juergen Wolf, Adrian G.Sacher, Suresh S.Ramalingam, Christophe Dooms, Dong-Wan Kim, Alfred Addeo, Jayesh Desai, Martin Schuler, Pascale Tomasini, Qui Tran, Simon Jones, Agnes Ang, Abraham Anderson, Antreas A.Hindoyan, David S.Hong, Bob T.Li

Volltext

EN1-3. Largest evaluation of acquired resistance in KRAS p.G12C-mutated non-small cell lung cancer (NSCLC)and colorectal cancer (CRC) treated with sotorasib : plasma biomarker anal... von Takayasu Kurata, Bob T.Li, Vamsidhar Velcheti, Timothy J.Price, David S.Hong, Marwan G.Fakih, Dong-Wan Kim, Gerald Falchook, Jean Pierre Delord, Grace Dy, Suresh S.Ramalingam, John Strickler, Jurgen Wolf, Adrian Sacher, Alfredo Addeo, Hans Prenen, Antreas Hindoyan, Abraham Anderson, Agnes Ang, Ferdinandos Skoulidis

Volltext

ES2-3. PD-L1 expression in untreated EGFRm advanced NSCLC and response to EGFR-TKIs in FLAURA von Kazuhiko Nakagawa, Helen Brown, Johan Vansteenkiste, Manuel Cobo, Tom John, Craig Barker, Alexander Kohlmann, Alexander Todd, Matilde Saggese, Juliann Chmielecki, Aleksandra Markovets, Suresh S.Ramalingam

Volltext

ES3-3. Mechanisms of acquired resistance to first-line osimertinib : preliminary data from the FLAURA study von Fumio Imamura, Ying Cheng, Caicun Zhou, Yuichiro Ohe, Byoung Chul Cho, Meng-Chih Lin, Margarita Majem, Riyaz Shah, Yuri Rukazenkov, Alexander Todd, Aleksandra Markovets, Carl Barrett, Juliann Chmielecki, Jhanelle E.Gray, Suresh S.Ramalingam

Volltext